Advertisement

A Systematic Review on the Incidence of Stent Migration in the Treatment of Acute and Chronic Iliofemoral Disease Using Dedicated Venous Stents

Published:January 17, 2022DOI:https://doi.org/10.1016/j.avsg.2021.12.084

      Objectives

      This systematic review investigated the incidence of stent migration in patients with acute and chronic deep venous iliofemoral disease who were treated with dedicated venous stents. Procedural approaches, clinical and stent patency outcomes, and other complications are described.

      Methods

      MEDLINE and Embase were searched for literature published from January, 2012 to December, 2021. Evidence on the study population and procedural characteristics, and outcomes related to symptomatic changes, health-related quality of life, stent patency and complications was presented.

      Results

      Fourty-two studies were identified from 857 articles found through the database searches. Five-hundred seventy acute deep vein thrombosis patients and 2,859 chronic disease patients were included. Ten dedicated venous stent brands were employed. There were six episodes of stent migration (0.17% of patients) of which three involved a closed-cell stent and one involved a hybrid-design stent. The 12-month primary patency rate in patients with acute deep vein thrombosis ranged from 86 to 88%, whilst secondary patency was 96%. Amongst the chronic-disease cohort the primary and secondary patency were noted to range from 59 to 94%, and 87 to 100%, respectively. The pooled 12-month primary and secondary stent patency rates were 73.8% and 91.5%, respectively.

      Conclusions

      Iliofemoral stenting using dedicated venous stents is associated with a low rate of stent migration although this may be due to a lack of reporting. Further research with specific surveillance protocols is necessary to reliably determine the true incidence of stent migration.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Annals of Vascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Kahn SR.
        The post thrombotic syndrome.
        Thromb Res. 2011; 127 (S89–92)
        • Walshe C.
        Living with a venous leg ulcer: a descriptive study of patients'experiences.
        J Adv Nurs. 1995; 22: 1092-1100
        • Phillips T
        • Stanton B
        • Provan A
        • et al.
        A study of the impact of leg ulcers on quality of life: financial, social, and psychologic implications.
        J Am Acad Dermatol. 1994; 31: 49-53
        • Enden T
        • Haig Y
        • Kløw N-E
        • et al.
        Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial.
        Lancet. 2012; 379: 31-38
        • Vedantham S
        • Goldhaber SZ
        • Julian JA
        • et al.
        Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis.
        N Engl J Med. 2017; 377: 2240-2252
        • Schwein A
        • Georg Y
        • Lejay A
        • et al.
        Endovascular treatment for venous diseases: where are the venous stents?.
        Methodist Debakey Cardiovasc J. 2018; 14: 208-213
        • Badesha AS
        • Bains PR
        • Bains BR
        • Khan T
        A systematic review and meta-analysis of the treatment of obstructive chronic deep venous disease using dedicated venous stents.
        Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2022; 10: 267-282
      1. U.S. Food & Drug Administration. Boston Scientific Corporation Recalls VICI VENOUS STENT System and VICI RDS VENOUS STENT System for Potential of Stent Migration [Internet]. 2021 [cited 2021 Jul 2]. Available from: https://www.fda.gov/medical-devices/medical-device-recalls/boston-scientific-corporation-recalls-vici-venous-stent-system-and-vici-rds-venous-stent-system.

        • Steinberg DO E
        • Gentile MD C
        • Heller MD M
        • et al.
        Intracardiac venous stent migration: emergency department presentation of a catastrophic complication.
        J Emerg Med. 2017; 53 (e11–3)
        • Holst T
        • Großwendt T
        • Laham MM
        • et al.
        Acute stent migration into the right ventricle in a patient with iliac vein stenting.
        Thorac Cardiovasc Surg Reports. 2018; 7 (e7–8)
        • Slonim SM
        • Dake MD
        • Razavi MK
        • et al.
        Management of misplaced or migrated endovascular stents.
        J Vasc Interv Radiol. 1999; 10: 851-859
      2. National Institute for Health and Care Excellence (NICE). Healthcare databases advanced search [Internet]. [cited 2020 Sep 14]. Available from: https://hdas.nice.org.uk/.

        • Launois R
        • Reboul-Marty J
        • Henry B.
        Construction and validation of a quality of life questionnaire in chronic lower limb venous insufficiency (CIVIQ).
        Qual life Res. 1996; 5: 539-554
        • Sterne JAC
        • Hernán MA
        • Reeves BC
        • et al.
        ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
        BMJ. 2016; 355 (i4919)
        • Guyatt GH
        • Oxman AD
        • Vist GE
        • et al.
        GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.
        BMJ. 2008; 336: 924-926
        • Wallace BC
        • Dahabreh IJ
        • Trikalinos TA
        • et al.
        Closing the gap between methodologists and end-users: R as a computational back-end.
        J Stat Softw. 2012; 49: 1-15
        • Lipsey MW
        • Wilson DB.
        Practical meta-analysis.
        Thousand Oaks, CA: Sage, 2001
        • Higgins JPT
        • Thomas J
        • Chandler J
        • et al.
        Cochrane Handbook for Systematic Reviews of Interventions.
        (editors)2nd ed. John Wiley & Sons, Chichester2019
      3. Rohatgi A. WebPlotDigitizer [Internet]. Pacifica, California, USA; [cited 2020 Sep 7]. Available from: https://automeris.io/WebPlotDigitizer.

        • Guyot P
        • Ades AE
        • Ouwens MJNM
        • et al.
        Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.
        BMC Med Res Methodol. 2012; 12: 9
        • Core Team R
        R: A language and environment for statistical computing [Internet].
        R Foundation for Statistical Computing, Vienna, Austria2020 (Available from)
        • Dopheide JF
        • Sebastian T
        • Engelberger RP
        • et al.
        Early clinical outcomes of a novel rheolytic directional thrombectomy technique for patients with iliofemoral deep vein thrombosis.
        Vasa. 2017; 47: 56-62
        • Dumantepe M
        • Uyar I.
        The effect of Angiojet rheolytic thrombectomy in the endovascular treatment of lower extremity deep venous thrombosis.
        Phlebology. 2018; 33: 388-396
        • Strijkers RHW
        • Grommes J
        • Arnoldussen CWKP
        • et al.
        Ultrasound-accelerated catheter-directed thrombolysis in acute iliofemoral deep venous thrombosis.
        J Vasc surgery Venous Lymphat Disord. 2013; 1: 225-230
        • Engelberger RP
        • Stuck A
        • Spirk D
        • et al.
        Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis: 1-year follow-up data of a randomized-controlled trial.
        J Thromb Haemost. 2017; 15: 1351-1360
        • Engelberger RP
        • Spirk D
        • Willenberg T
        • et al.
        Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis.
        Circ Cardiovasc Interv. 2015; 8: e002027
        • Engelberger RP
        • Fahrni J
        • Willenberg T
        • et al.
        Fixed low-dose ultrasound-assisted catheter-directed thrombolysis followed by routine stenting of residual stenosis for acute ilio-femoral deep-vein thrombosis.
        Thromb Haemost. 2014; 111: 1153-1160
        • Loffroy R
        • Falvo N
        • Guillen K
        • et al.
        Single-session percutaneous mechanical thrombectomy using the aspirex®s device plus stenting for acute iliofemoral deep vein thrombosis: Safety, efficacy, and mid-term outcomes.
        Diagnostics (Basel). 2020; 10: 544
        • Notten P
        • ten Cate-Hoek AJ
        • Arnoldussen CWKP
        • et al.
        Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial.
        Lancet Haematol. 2020; 7 (e40–9)
        • O'Sullivan GJ
        • Sheehan J
        • Lohan D
        • et al.
        Iliofemoral venous stenting extending into the femoral region: initial clinical experience with the purpose-designed Zilver Vena stent.
        J Cardiovasc Surg. 2013; 54: 255-261
        • Sebastian T
        • Engelberger RP
        • Spirk D
        • et al.
        Cessation of anticoagulation therapy following endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis.
        Vasa. 2019; 48: 331-339
        • Sebastian T
        • Hakki LO
        • Spirk D
        • et al.
        Rivaroxaban or vitamin-K antagonists following early endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis.
        Thromb Res. 2018; 172: 86-93
        • Lichtenberg MKW
        • de Graaf R
        • Stahlhoff WF
        • et al.
        Venovo venous stent in the treatment of non-thrombotic or post-thrombotic iliac vein lesions – short-term results from the Arnsberg venous registry.
        Vasa. 2019; 48: 175-180
        • Black S
        • Gwozdz A
        • Karunanithy N
        • et al.
        Two year outcome after chronic iliac vein occlusion recanalisation using the vici venous stent®.
        Eur J Vasc Endovasc Surg. 2018; 56: 710-718
        • Razavi MK
        • Black S
        • Gagne P
        • et al.
        Pivotal study of endovenous stent placement for symptomatic iliofemoral venous obstruction.
        Circ Cardiovasc Interv. 2019; 12e008268
        • van Vuuren TMAJ
        • de Wolf MAF
        • Arnoldussen CWKP
        • et al.
        Editor's choice – reconstruction of the femoro-ilio-caval outflow by percutaneous and hybrid interventions in symptomatic deep venous obstruction.
        Eur J Vasc Endovasc Surg. 2017; 54: 495-503
        • Hall TC
        • Braithwaite BD
        • O'Neill R
        • et al.
        Endovenous management of chronic venous insufficiency.
        Angiol e Cir Vasc. 2019; 15: 226-230
        • Moini M
        • Zafarghandi M
        • Taghavi M
        • et al.
        Venoplasty and stenting in post-thrombotic syndrome and non-thrombotic iliac vein lesion.
        Minim Invasive Ther Allied Technol. 2019; 29: 1-7
        • de Graaf R
        • de Wolf M
        • Sailer AM
        • et al.
        Iliocaval confluence stenting for chronic venous obstructions.
        Cardiovasc Intervent Radiol. 2015; 38: 1198-1204
        • Sebastian T
        • Spirk D
        • Engelberger RP
        • et al.
        Incidence of stent thrombosis after endovascular treatment of iliofemoral or caval veins in patients with the postthrombotic syndrome.
        Thromb Haemost. 2019; 119: 2064-2073
        • Barbati ME
        • Gombert A
        • Toonder IM
        • et al.
        Iliocaval skip stent reconstruction technique for chronic bilateral iliocaval venous occlusion.
        J Vasc Interv Radiol. 2020; 31: 2060-2065
        • Huang IKH
        • Pua U
        • Quek LHH
        • et al.
        Iliac vein pathology and short-term stenting outcomes in a South-East Asian population: A single-centre experience.
        J Med Imaging Radiat Oncol. 2021; 65: 46-53
        • Lichtenberg MKW
        • Stahlhoff WF
        • Stahlhoff S
        • et al.
        Venovo venous stent for treatment of non-thrombotic or post-thrombotic iliac vein lesions – long-term efficacy and safety results from the Arnsberg venous registry.
        Vasa. 2020; 50: 1-7
        • Lim MNHH
        • Damodharan K
        • Chan SL
        • et al.
        Endovascular deep vein stenting of symptomatic post-thrombotic and non-thrombotic iliac vein stenotic lesions: a multicentre cohort experience from Singapore.
        Ann Acad Med Singapore. 2020; 49: 551-560
        • Lichtenberg M
        • de Graaf R
        • Stahlhoff WF
        • et al.
        Patency rates, safety and clinical results of the sinus-Obliquus venous stent in the treatment of chronic ilio-femoral venous outflow obstruction – data from the Arnsberg venous registry.
        Vasa. 2019; 48: 270-275
        • Moeri L
        • Lichtenberg M
        • Gnanapiragasam S
        • et al.
        Braided or laser-cut self-expanding nitinol stents for the common femoral vein in patients with post-thrombotic syndrome.
        J Vasc surgery Venous Lymphat Disord. 2021; 9: 760-769
        • Salem AM
        • AboElNeel HA
        • Fakhr ME
        Long term outcome of dedicated venous stents in management of chronic ilio-femoral obstruction.
        Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2022; 10: 52-59
        • Sebastian T
        • Gnanapiragasam S
        • Spirk D
        • et al.
        Self-expandable nitinol stents for the treatment of nonmalignant deep venous obstruction.
        Circ Cardiovasc Interv. 2020; 13 (e009673-374)
        • Tang TY
        • Lim MHH
        • Damodharan K
        • et al.
        Use of the VENOVOTM and Sinus ObliquusTM venous stents in the treatment of non-thrombotic or post-thrombotic iliac vein lesions – Short-term results from a multi-centre Asian cohort.
        Phlebology. 2021; 36: 70-78
        • Piao L
        • Barbati ME
        • Shekarchian S
        • et al.
        Comparison of endovascular strategy versus hybrid procedure in treatment of chronic venous obstructions involving the confluence of common femoral vein.
        Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2022; 10: 334-341
        • Sebastian T
        • Barco S
        • Lichtenberg M
        • et al.
        Twelve-month clinical outcomes of a hybrid oblique self-expanding nitinol stent used for the treatment of post-thrombotic syndrome with common iliac vein compression: The TOPOS study.
        Vasc Med. 2021; 26: 569-571
        • Dake MD
        • O'Sullivan G
        • Shammas NW
        • et al.
        Three-year results from the venovo venous stent study for the treatment of iliac and femoral vein obstruction.
        Cardiovasc Intervent Radiol. 2021; 44: 1918-1929
        • de Wolf F
        • Arnoldussen MA
        • Grommes CW
        • et al.
        Minimally invasive treatment of chronic iliofemoral venous occlusive disease.
        J Vasc Surg Venous Lymphat Disord. 2013; 1: 146-153
        • van Vuuren TMAJ
        • Doganci S
        • Wittens CHA.
        Patency rates and clinical outcomes in a cohort of 200 patients treated with a dedicated venous stent.
        J Vasc Surg Venous Lymphat Disord. 2018; 6: 321-329
        • Stuck AK
        • Reich T
        • Engelberger RP
        • et al.
        Endovascular treatment of post-thrombotic and non-thrombotic iliofemoral venous outflow obstructions with self-expanding nitinol stents.
        Vasa. 2018; 47: 319-325
        • Lichtenberg M
        • Breuckmann F
        • Stahlhoff WF
        • et al.
        Placement of closed-cell designed venous stents in a mixed cohort of patients with chronic venous outflow obstructions – short-term safety, patency, and clinical outcomes.
        Vasa. 2018; 47: 475-481
        • Razavi M
        • Marston W
        • Black S
        • et al.
        The initial report on 1-year outcomes of the feasibility study of the VENITI VICI VENOUS STENT in symptomatic iliofemoral venous obstruction.
        J Vasc Surg Venous Lymphat Disord. 2018; 6: 192-200
        • Guillen K
        • Falvo N
        • Nakai M
        • et al.
        Endovascular stenting for chronic femoro-iliac venous obstructive disease: clinical efficacy and short-term outcomes.
        Diagn Interv Imaging. 2020; 101: 15-23
        • de Wolf MAF
        • de Graaf R
        • Kurstjens RLM
        • et al.
        Short-term clinical experience with a dedicated venous nitinol stent: initial results with the sinus-venous stent.
        Eur J Vasc Endovasc Surg. 2015; 50: 518-526
        • Stuck AK
        • Kunz S
        • Baumgartner I
        • et al.
        Patency and clinical outcomes of a dedicated, self-expanding, hybrid oblique stent used in the treatment of common iliac vein compression.
        J Endovasc Ther. 2017; 24: 159-166
        • Xu H
        • Tian Y
        • Zhang J
        • et al.
        Clinical outcomes of venous self-expanding stent placement for iliofemoral venous outflow obstruction.
        Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2021; 9: 1178-1184
        • Tosenovsky P.
        One-year results of Iliocaval stenting.
        Ann Vasc Surg. 2019; 59: 208-216
        • O'Sullivan GJ
        • Karunanithy N
        • Binkert CA
        • et al.
        One year outcomes of the VIVO-EU study of treatment of symptomatic iliofemoral outflow obstruction with the zilver vena venous self-expanding stent.
        Cardiovasc Intervent Radiol. 2021; 44: 1930-1936
        • de Wolf MAF
        • de Graaf R
        • Kurstjens R
        • et al.
        Short-term clinical experience with a dedicated venous stent.
        J Vasc Surg Venous Lymphat Disord. 2013; 2: 116
        • van Vuuren TMAJ
        • de Wolf MAF
        • Arnoldussen CWKP
        • et al.
        Reconstruction of the femoro-ilio-caval outflow by percutaneous and hybrid interventions in symptomatic deep venous obstruction.
        J Vasc Surg. 2017; 66: 1628
        • Kakkos SK
        • Gohel M
        • Baekgaard N
        • et al.
        Editor's choice – European society for vascular surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis.
        Eur J Vasc Endovasc Surg. 2021; 61: 9-82
        • Wittens C
        • Davies AH
        • Bækgaard N
        • et al.
        Editor's choice – management of chronic venous disease.
        Eur J Vasc Endovasc Surg. 2015; 49: 678-737
        • Shammas N.
        Avoiding Iliac vein stent migration: techniques and appropriate sizing.
        Vasc Dis Manag. 2017; 14: E247-E248
        • Shamimi-Noori SM
        • Clark TWI.
        Venous stents: current status and future directions.
        Tech Vasc Interv Radiol. 2018; 21: 113-116
        • Black S
        • Morris R.
        The unknowns of venous stenting: why do good cases go bad?.
        Endovasc Today. 2019; 18: 65-69
        • Raju S
        • Buck WJ
        • Crim W
        • et al.
        Optimal sizing of iliac vein stents.
        Phlebology. 2018; 33: 451-457
        • Gagne PJ
        • Tahara RW
        • Fastabend CP
        • et al.
        Venography versus intravascular ultrasound for diagnosing and treating iliofemoral vein obstruction.
        J Vasc surgery Venous Lymphat Disord. 2017; 5: 678-687
        • Rathore A
        • Gloviczki P
        • Bjarnason H.
        Open surgical removal of iliac vein Wallstents with excision of pseudointima obstructing the contralateral iliac vein.
        J Vasc Surg Venous Lymphat Disord. 2016; 4: 525-529
        • Shammas NW.
        Worsening back and lower leg pain post stenting of the common Iliac vein: is there evidence it is related to stent size?.
        J Invasive Cardiol. 2020; 32 (E250–3)
        • Mahnken AH
        • Thomson K
        • de Haan M
        • et al.
        CIRSE standards of practice guidelines on Iliocaval stenting.
        Cardiovasc Intervent Radiol. 2014; 37: 889-897
        • Schechter MA
        • O'Brien PJ
        • Cox MW.
        Retrieval of iatrogenic intravascular foreign bodies.
        J Vasc Surg. 2013; 57: 276-281
        • Khalid MO
        • Moskovits N
        • Frankel RA
        • et al.
        Venous stent migrating to the right heart causing severe regurgitation.
        J Investig Med High Impact Case Reports. 2020; 8 (2324709620974220)
        • Yankov G
        • Petkov R
        • Mekov E
        • et al.
        Migration of bare-metal stent placed in the right iliac vein into the right pulmonary artery.
        Ann Thorac Surg. 2020; 110 (e205–7)
        • Sharma AK
        • Ganatra S
        • Hansen J
        • et al.
        A dual-snare percutaneous retrieval of venous stent embolization to the right heart.
        JACC Cardiovasc Interv. 2017; 10 (e111–3)
        • Raju S
        • Tackett Jr P
        • Neglen P
        Reinterventions for nonocclusive iliofemoral venous stent malfunctions.
        J Vasc Surg. 2009; 49: 511-518